MetLife, Inc.
MET
$81.07
-$0.34-0.42%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -21.82% | 35.62% | |||
| Total Other Revenue | 117.38% | 662.79% | |||
| Total Revenue | -19.90% | 37.17% | |||
| Cost of Revenue | -29.21% | 49.41% | |||
| Gross Profit | 19.73% | 1.71% | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 3.33% | 5.59% | |||
| Total Operating Expenses | -24.31% | 40.62% | |||
| Operating Income | 70.14% | -8.63% | |||
| Income Before Tax | 34.91% | -7.69% | |||
| Income Tax Expenses | 14.62% | -2.27% | |||
| Earnings from Continuing Operations | 42.40% | -9.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 428.57% | -16.67% | |||
| Net Income | 46.48% | -9.71% | |||
| EBIT | 70.14% | -8.63% | |||
| EBITDA | 8.04% | 42.58% | |||
| EPS Basic | 47.90% | -3.93% | |||
| Normalized Basic EPS | 40.92% | -6.95% | |||
| EPS Diluted | 48.74% | -4.11% | |||
| Normalized Diluted EPS | 40.99% | -6.92% | |||
| Average Basic Shares Outstanding | -0.93% | -0.99% | |||
| Average Diluted Shares Outstanding | -0.98% | -1.03% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.30% | 0.01% | |||